4Filed Aug 11, 8:00 PM ET

Transcat (TRNS) Director Christopher P. Gillette Sells 504 Shares

$TRNS · TRANSCAT INC

Research Summary

AI-generated summary of this SEC filing

Updated

Transcat (TRNS) Director Christopher P. Gillette Sells 504 Shares

What Happened

  • Christopher P. Gillette, a director of Transcat Inc. (TRNS), sold 504 shares in an open-market transaction on August 7, 2026. The shares traded at $94.23 per share for a total transaction value of $47,494. This was a sale (S), which is often routine insider selling and does not by itself indicate the director's view of the company.

Key Details

  • Transaction date: 2026-08-07
  • Price per share: $94.23; Shares sold: 504; Total proceeds: $47,494
  • Transaction type: Open-market sale (code S)
  • Shares owned after transaction: Not specified in the supplied filing excerpt
  • Footnotes in the filing:
    • F1: Certain restricted stock units convert one-for-one to common shares and vest on Sept 10, 2026 (subject to award terms).
    • F2: An option referenced in the filing vests pro rata over five annual anniversaries from grant (subject to award terms).
  • Filing timeliness: The Form 4 was filed on Aug 12, 2026 for an Aug 7 transaction; Form 4s are generally required within two business days, so this appears to be filed late (transactionTimeliness = 'L'). Late filings can draw regulatory scrutiny and should be noted by investors.
  • Remarks: Exhibit 24 (Power of Attorney) was included in the filing.

Context

  • This report documents an open-market sale, not an option exercise or award receipt. Sales by directors can be routine (liquidity, diversification, taxes) and should be interpreted cautiously; they are factual disclosures rather than proof of company outlook. The footnotes indicate the director has awards (RSUs and options) with standard vesting schedules that may result in future share issuances.